Practical Synthesis Routes Towards Antitumor Antibiotic Duocarmycin SA
抗肿瘤抗生素 Duocarmycin SA 的实用合成路线
基本信息
- 批准号:07672305
- 负责人:
- 金额:$ 1.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Duocarmycin SA (1) is the most potent and most stable member among the antitumor antibiotics, including CC-1065 and Duocarmycin A,which bear cyclopropa [c] pyrrolo [3,2-e] indole pharmacophore.Our recent studies on the synthesis of this antibiotic clminated in achievement of three distinctive synthesis routes which are applicable to the preparation of synthetic analogs of 1.The initial rote realized the first enantio-selective synthesis of (+) -1. Pyrrolo [3,2-f] quinolinol derivative (2) , prepared from methyl 5-acetyl-4-bromopyrrole-2-carboxylate (3) in the steps, was readily optically resolved by use of Chiralcel OD HPLC column to (S)-2 and (R)-2. The former was led to (+) -1, and the latter unnatural isomer, was inverted to (S)-2 under the Mitsunobu reaction conditions. An enatio-convergent synthesis of (+) -1 was thus established.The second rote wa most featred by methyl 4- (methoxycarbonyloxy) pyrrolo [3,2-f] quinoline-2-carboxylate (4). The pyrrole derivative 3 was copled with 2-fluoro-3- (trimethylstannyl) pyridine under the Stille reaction conditions, and the resulting pyridylpyrrole derivative was cyclized to 4 in five steps involving a palladim-catalyzed arylation reaction of the acetyl group. It was then readily transformed to ( (]SY.+-。[) ) -2. The overall yield was much improved by this rote, and it was applied to the preparation of DSA furan and thiophene analogs.The third route is the first asymmetirc synthesis without an optical resolution among the syntheses of the duocarmycin class of antibiotics. A highly functionalized optica active indole derivative was prepared from L-malic acid adoptiong our indole formation reaction. The following C-ring formation gave the enatiomerically pure (S) -2, completing the third route. The absolute structure of (+) -1 was unequivocally established by this study.A further elaboration is now in progress.
Duocarmycin SA(1)是包括CC-1065和Duocarmycin A在内的具有环丙[c]吡咯[3,2-e]吲哚药效团的抗肿瘤抗生素中最有效、最稳定的成员。我们最近对这种抗生素的合成研究最终获得了三条不同的合成路线,适用于1的合成类似物的制备。最初的机器实现了(+)-1的首次对映体选择性合成。由5-乙酰-4-溴吡咯-2-羧酸甲酯(3)合成的吡咯[3,2-f]喹啉酚衍生物(2),利用Chiralcel OD高效液相色谱柱容易光学分解为(S)-2和(R)-2。前者在Mitsunobu反应条件下被转化为(+)-1,后者的非自然异构体被转化为(S)-2。这样就建立了(+)-1的生成收敛合成。第二种结构主要是甲基4-(甲氧基羰基)吡咯[3,2-f]喹啉-2-羧酸盐(4)。在Stille反应条件下,吡咯衍生物3与2-氟-3-(三甲基锡基)吡啶偶联,得到的吡咯衍生物在钯催化的乙酰基芳化反应中经过5步环化得到4。然后,它很容易转化为(()SY.+-。[)] 2。该方法可用于呋喃和噻吩类似物的制备。第三种途径是多霉素类抗生素合成中第一个无光学分辨的不对称合成途径。以l -苹果酸为原料,采用吲哚生成反应制备了高功能化的光学活性吲哚衍生物。接下来的c环形成得到了纯的(S) -2,完成了第三条路线。本研究明确了(+)-1的绝对结构。进一步的阐述目前正在进行中。
项目成果
期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hideaki Muratake, Itsuko Abe, Mitsutaka Natsume: "Total Synthesis of an Antitumor Antibiotic, ( (]SY.+-。[) ) -Duocarmycin SA" Tetrahedron Letters. Vol. 35, No 16. 2573-2576 (1994)
Hideaki Muratake、Itsuko Abe、Mitsutaka Natsume:“抗肿瘤抗生素的全合成,((]SY.+-.[))-Duocarmycin SA”Tetrahedron Letters,第 35 卷,第 16 期。2573-2576 (1994)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H. Muratake: "Total Synthesis of Natural(+)-Duocarmycin SA." Chem. Pharm. Bull.43. 1064-1066 (1995)
H. Muratake:“天然 ( )-Duocarmycin SA 的全合成。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hideaki Miyaki Tongawa, , Mitsutaka Natsume: "Alternative Synthesis of Duocarmycin SA Using a Tricyclic Heteroaromatic Intermediate Prepared by Palladim-Catalyzed Coupling Reactions" Chemical & Pharmaceutical Bulletin. Vol. 44, No 8. 1631-1633 (1996)
Hideaki Miyaki Tongawa、Mitsutaka Natsume:“使用 Palladim 催化偶联反应制备的三环杂芳族中间体替代合成 Duocarmycin SA”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H. Muratake: "Total Synthesis of an Antitumor Antibiotic, (±)-Duocarmycin SA." Tetrahedron Letters. 35. 2573-2576 (1994)
H. Muratake:“抗肿瘤抗生素的全合成,(±)-Duocarmycin SA。”35. 2573-2576 (1994)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H.Muratake: "Total Synthesis of Natural (+)-Duocarmycin SA." Chem.Pharm.Bull.43. 1064-1066 (1995)
H.Muratake:“天然 ( )-Duocarmycin SA 的全合成。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MURATAKE Hideaki其他文献
MURATAKE Hideaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MURATAKE Hideaki', 18)}}的其他基金
Synthetic Studies of Kobusine-type Aconite Alkaloids
科布辛型附子生物碱的合成研究
- 批准号:
16590025 - 财政年份:2004
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Construction of Polycycles Using Palladium-Catalyzed α-Arylation Reaction toward Carbonyl Group
利用钯催化的羰基 α-芳基化反应构建多环
- 批准号:
10672014 - 财政年份:1998
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Enediyne Antitumor Antibiotic Synthesis - Streptomycetes
烯二炔抗肿瘤抗生素合成 - 链霉菌
- 批准号:
6898468 - 财政年份:2001
- 资助金额:
$ 1.47万 - 项目类别:
Enediyne Antitumor Antibiotic Synthesis - Streptomycetes
烯二炔抗肿瘤抗生素合成 - 链霉菌
- 批准号:
6643502 - 财政年份:2001
- 资助金额:
$ 1.47万 - 项目类别:
Enediyne Antitumor Antibiotic Synthesis - Streptomycetes
烯二炔抗肿瘤抗生素合成 - 链霉菌
- 批准号:
6475243 - 财政年份:2001
- 资助金额:
$ 1.47万 - 项目类别:
Enediyne Antitumor Antibiotic Synthesis - Streptomycetes
烯二炔抗肿瘤抗生素合成 - 链霉菌
- 批准号:
6743720 - 财政年份:2001
- 资助金额:
$ 1.47万 - 项目类别:
Enediyne Antitumor Antibiotic Synthesis - Streptomycetes
烯二炔抗肿瘤抗生素合成 - 链霉菌
- 批准号:
6532903 - 财政年份:2001
- 资助金额:
$ 1.47万 - 项目类别:
DNA ALKYLATION BY THE ANTITUMOR ANTIBIOTIC LEINAMYCIN
抗肿瘤抗生素莱纳霉素对 DNA 进行烷基化
- 批准号:
6031193 - 财政年份:1999
- 资助金额:
$ 1.47万 - 项目类别:
DNA ALKYLATION BY THE ANTITUMOR ANTIBIOTIC LEINAMYCIN
抗肿瘤抗生素莱纳霉素对 DNA 进行烷基化
- 批准号:
6475859 - 财政年份:1999
- 资助金额:
$ 1.47万 - 项目类别:
FUNCTIONAL ANALYSIS AND MODIFICATION OF NOVEL MACROLACTAM ANTITUMOR ANTIBIOTIC
新型大内酰胺抗肿瘤抗生素的功能分析及修饰
- 批准号:
11480160 - 财政年份:1999
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B).